Kashiwagi, S., Fukushima, W., Asano, Y., Goto, W., Takada, K., Noda, S., . . . Ohsawa, M. (2017). Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer. BMC Cancer, 17, 1. https://doi.org/10.1186/s12885-017-3598-5
Chicago Style (17th ed.) CitationKashiwagi, Shinichiro, et al. "Identification of Predictive Markers of the Therapeutic Effect of Eribulin Chemotherapy for Locally Advanced or Metastatic Breast Cancer." BMC Cancer 17 (2017): 1. https://doi.org/10.1186/s12885-017-3598-5.
MLA (9th ed.) CitationKashiwagi, Shinichiro, et al. "Identification of Predictive Markers of the Therapeutic Effect of Eribulin Chemotherapy for Locally Advanced or Metastatic Breast Cancer." BMC Cancer, vol. 17, 2017, p. 1, https://doi.org/10.1186/s12885-017-3598-5.